» Articles » PMID: 37454242

A Potential Osteogenic Role for MicroRNA-181a-5p During Palatogenesis

Overview
Journal Eur J Orthod
Specialty Dentistry
Date 2023 Jul 15
PMID 37454242
Authors
Affiliations
Soon will be listed here.
Abstract

Background: In a previous study, we found that the highly conserved hsa-miR-181a-5p is downregulated in palatal fibroblasts of non-syndromic cleft palate-only infants.

Objectives: To analyze the spatiotemporal expression pattern of mmu-miR-181a-5p during palatogenesis and identify possible mRNA targets and their involved molecular pathways.

Material And Methods: The expression of mmu-miR-181a-5p was analyzed in the developing palates of mouse embryos from E11 to E18 using qPCR and ISH. Mouse embryonic palatal mesenchyme cells from E13 were used to analyze mmu-miR-181a-5p expression during osteogenic differentiation. Differential mRNA expression and target identification were analyzed using whole transcriptome RNA sequencing after transfection with a mmu-miR-181a-5p mimic. Differentially expressed genes were linked with underlying pathways using gene set enrichment analysis.

Results: The expression of mmm-miR-181a-5p in the palatal shelves increased from E15 and overlapped with palatal osteogenesis. During early osteogenic differentiation, mmu-miR-181a-5p was upregulated. Transient overexpression resulted in 49 upregulated mRNAs and 108 downregulated mRNAs (adjusted P-value < 0.05 and fold change > ± 1.2). Ossification (Stc1, Mmp13) and cell-cycle-related GO terms were significantly enriched for upregulated mRNAs. Analysis of possible mRNA targets indicated significant enrichment of Hippo signaling (Ywhag, Amot, Frmd6 and Serpine1) and GO terms related to cell migration and angiogenesis.

Limitations: Transient overexpression of mmu-miR-181a-5p in mouse embryonic palatal mesenchyme cells limited its analysis to early osteogenesis.

Conclusion: Mmu-miR-181-5p expression is increased in the developing palatal shelves in areas of bone formation and targets regulators of the Hippo signaling pathway.

Citing Articles

FBXO22 is a potential therapeutic target for recurrent chondrosarcoma.

Xin B, Chen H, Zhu Z, Guan Q, Bai G, Yang C J Bone Oncol. 2024; 46:100605.

PMID: 38742151 PMC: 11089373. DOI: 10.1016/j.jbo.2024.100605.

References
1.
Schoen C, Aschrafi A, Thonissen M, Poelmans G, Von den Hoff J, Carels C . MicroRNAs in Palatogenesis and Cleft Palate. Front Physiol. 2017; 8:165. PMC: 5378724. DOI: 10.3389/fphys.2017.00165. View

2.
Bhushan R, Grunhagen J, Becker J, Robinson P, Ott C, Knaus P . miR-181a promotes osteoblastic differentiation through repression of TGF-β signaling molecules. Int J Biochem Cell Biol. 2012; 45(3):696-705. DOI: 10.1016/j.biocel.2012.12.008. View

3.
Mukhopadhyay P, Brock G, Pihur V, Webb C, Pisano M, Greene R . Developmental microRNA expression profiling of murine embryonic orofacial tissue. Birth Defects Res A Clin Mol Teratol. 2010; 88(7):511-34. PMC: 3146018. DOI: 10.1002/bdra.20684. View

4.
Zhao F, Yang G, Feng M, Cao Z, Liu Y, Qiu J . Expression, function and clinical application of stanniocalcin-1 in cancer. J Cell Mol Med. 2020; 24(14):7686-7696. PMC: 7348177. DOI: 10.1111/jcmm.15348. View

5.
Jin H, Gonzalez-Martin A, Miletic A, Lai M, Knight S, Sabouri-Ghomi M . Transfection of microRNA Mimics Should Be Used with Caution. Front Genet. 2015; 6:340. PMC: 4667072. DOI: 10.3389/fgene.2015.00340. View